Article
A benchmarking of deep neural network models for cancer subtyping using single point mutations
2022-07-24
Abstract excerpt
It is now well-known that genetic mutations contribute to development of tumors, in which at least 15% of cancer patients experience a causative genetic abnormality including De Novo somatic point mutations. This highlights the importance of identifying responsible mutations and the associated biomarkers (e.g., genes) for early detection in high-risk cancer patients. The next-generation sequencing technologies ha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 79bf8430-7fe5-5068-ba2a-995b3d80c68b
- DOI
- 10.1101/2022.07.24.501264
